2U3:FRA
Alcon AG
€68,50
arrow_upward
+1,39%(+0,94) 1D
5 Nov., 22:00:00 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 2U3...
Open
€68,50
High
€68,50
Low
€68,50
Mkt. cap
31,23Â mjd
Avg. vol.
221,00
Volume
0,00
52-wk high
€73,96
52-wk low
€51,78
No. of employees
25Â k
Open
€68,50
High
€68,50
Low
€68,50
Mkt. cap
31,23Â mjd
Avg. vol.
221,00
Volume
0,00
52-wk high
€73,96
52-wk low
€51,78
No. of employees
25Â k
News stories
From web sources and news partners
Yahoo Finance
·
9 uur gelede
Countdown to Alcon (ALC) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Yahoo Finance
·
10 uur gelede
Alcon (ALC) Surges 6.8%: Is This an Indication of Further Gains?
Investing.com
·
3 dae gelede
Needham reiterates Alcon stock rating on Neurotech acquisition
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25Â k
Founded1945
HeadquartersGenève, Geneva, Switserland
SectorHealth Care
IndustryMedical device
Websitealcon.com